🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lee Ainslie’s WST Holdings & Trades

First Buy
Q3 2018
Duration Held
10 Quarters
Largest Add
Q4 2018
+57,790 Shares
Current Position
722 Shares
$267,689 Value

Lee Ainslie's WST Position Overview

Lee Ainslie (via Maverick Capital LTD) currently holds 722 shares of West Pharmaceutical Services, Inc. (WST) worth $267,689, representing 0.00% of the portfolio. First purchased in 2018-Q3, this medium-term investment has been held for 10 quarters.

Based on 13F filings, Lee Ainslie has maintained a strategic position in WST, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2018, adding 57,790 shares. Largest reduction occurred in Q2 2019, reducing 98,230 shares.

Analysis based on 13F filings available since 2013 Q2

Lee Ainslie's West Pharmaceutical Services (WST) Holding Value Over Time

Track share changes against reported price movement

Quarterly West Pharmaceutical Services (WST) Trades by Lee Ainslie

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +722 New Buy 722 $370.76
Q2 2024 -994 Sold Out 0 $0.00
Q1 2024 +994 New Buy 994 $395.71
Q4 2021 -1,645 Sold Out 0 $0.00
Q3 2021 +1,558 Add 1790.80% 1,645 $424.32
Q2 2021 +87 New Buy 87 $356.32
Q2 2019 -98,230 Sold Out 0 $0.00
Q1 2019 -1,720 Reduce 1.72% 98,230 $110.20
Q4 2018 +57,790 Add 137.07% 99,950 $98.03
Q3 2018 +42,160 New Buy 42,160 $123.46

Lee Ainslie's West Pharmaceutical Services Investment FAQs

Lee Ainslie first purchased West Pharmaceutical Services, Inc. (WST) in Q3 2018, acquiring 42,160 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Lee Ainslie has held West Pharmaceutical Services, Inc. (WST) for 10 quarters since Q3 2018.

Lee Ainslie's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q4 2018, adding 99,950 shares worth $9.8 M.

According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 722 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $267,689.

As of the Q3 2026 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.00% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.

Lee Ainslie's peak holding in West Pharmaceutical Services, Inc. (WST) was 99,950 shares, as reported at the end of Q4 2018.